Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biocon Ltd Future - Jul 26
Track the Biocon share price today and view real-time BIONc1:NS share price data, including charts, technicals, and key financials. View the BIONc1:NS premarket stock price ahead of the market session or assess the after hours quote. Explore BIONc1:NS stock price movements, trading volume, and market activity across the NSE exchange.
What Is the Biocon Stock Price Today?
The Biocon stock price today is 427.30.
What Is the Stock Symbol for Biocon?
The stock symbol for Biocon is ""BIONc1:NS.""
What Stock Exchange Does Biocon Trade On?
Biocon is listed and trades on the NSE stock exchange.
Is Biocon a Good Stock to Buy?
Determining whether Biocon or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIONc1:NS quote. (ISIN: )
What Is the Biocon Stock Price Today?
The Biocon stock price today is 427.30.
What Is the Stock Symbol for Biocon?
The stock symbol for Biocon is ""BIONc1:NS.""
What Stock Exchange Does Biocon Trade On?
Biocon is listed and trades on the NSE stock exchange.
Is Biocon a Good Stock to Buy?
Determining whether Biocon or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIONc1:NS quote. (ISIN: )
427.30
+0.30(+0.07%)
Closed·
Day's Range
425.15
430.45
52 wk Range
332.00
448.50
Day's Range
425.15430.45
52 wk Range
332.00448.50
- Bid/Ask
- 432.35 / 432.80
- Prev. Close
- 427.1
- Open
- 427.25
- Day's Range
- 425.15-430.45
- 52 wk Range
- 332-448.5
- Bid/Ask
- 432.35 / 432.80
- Prev. Close
- 427.1
- Open
- 427.25
- Day's Range
- 425.15-430.45
- 52 wk Range
- 332-448.5
- Volume
- 4,927,500
- 1-Year Change
- 11.0447%
- Settlement Day
- 28/07/2026
- Settlement Type
- Cash
- Month
- Jul 26
- Last Rollover Day
- 30/06/2026
- Contract Size
- 600 shares
- Tick Size
- 0.05
- Tick Value
- 30
- Base Symbol
- -
- Point Value
- 1=₹600
- Months
- FGHJKMNQUVXZ
- Bid/Ask
- 432.35 / 432.80
- Prev. Close
- 427.1
- Open
- 427.25
- Day's Range
- 425.15-430.45
- 52 wk Range
- 332-448.5
- Volume
- 4,927,500
- 1-Year Change
- 11.0447%
- Settlement Day
- 28/07/2026
- Settlement Type
- Cash
- Month
- Jul 26
- Last Rollover Day
- 30/06/2026
- Contract Size
- 600 shares
- Tick Size
- 0.05
- Tick Value
- 30
- Base Symbol
- -
- Point Value
- 1=₹600
- Months
- FGHJKMNQUVXZ
Type:Equity
Underlying:Biocon
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
How do you feel today about BIONc1:NS?
Vote to see community's results!
or
Biocon receives Investment Bank Analyst Rating Update- Investing.com
Pro
Biocon receives Investment Bank Analyst Rating Update- Investing.com
Pro
Biocon receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Biocon launches denosumab biosimilars in US market- Investing.com
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
FAQ
What Is the Biocon (BIONc1:NS) Stock Price Today?
The Biocon stock price today is 427.30 INR.
What Stock Exchange Does Biocon Trade On?
Biocon is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Biocon?
The stock symbol for Biocon is "BIONc1:NS."
What Is the Biocon Market Cap?
As of today, Biocon market cap is 689.99B INR.
From a Technical Analysis Perspective, Is BIONc1:NS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Biocon Stock Split?
Biocon has split 0 times.
How Many Employees Does Biocon Have?
Biocon has 16447 employees.
What is the current trading status of Biocon (BIONc1:NS)?
As of 02/08/2026, Biocon (BIONc1:NS) is trading at a price of 427.30 INR, with a previous close of 427.10 INR. The stock has fluctuated within a day range of 425.15 INR to 430.45 INR, while its 52-week range spans from 332.00 INR to 448.50 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.